Accéder au contenu
Merck

PDE8 controls CD4

Cellular signalling (2017-08-31)
Chaitali P Basole, Rebecca K Nguyen, Katie Lamothe, Amanda Vang, Robert Clark, George S Baillie, Paul M Epstein, Stefan Brocke
RÉSUMÉ

The levels of cAMP are regulated by phosphodiesterase enzymes (PDEs), which are targets for the treatment of inflammatory disorders. We have previously shown that PDE8 regulates T cell motility. Here, for the first time, we report that PDE8A exerts part of its control of T cell function through the V-raf-1 murine leukemia viral oncogene homolog 1 (Raf-1) kinase signaling pathway. To examine T cell motility under physiologic conditions, we analyzed T cell interactions with endothelial cells and ligands in flow assays. The highly PDE8-selective enzymatic inhibitor PF-04957325 suppresses adhesion of in vivo myelin oligodendrocyte glycoprotein (MOG) activated inflammatory CD4

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Protein A from Staphylococcus aureus, Soluble, Cowan strain, recombinant, expressed in E. coli, aqueous solution, ≥95% (HPLC)